申请人:——
公开号:US20020128263A1
公开(公告)日:2002-09-12
This invention relates to a compound and the use of the compound of the formula
1
wherein R
1
, R
2
, R
3
, R
4
and R
5
are as defined in the description, A signifies —CH═CH— or —C≡C—; and B signifies
2
wherein R
6
to R
26
, X and Y are as defined in the specification or a pharmaceutically acceptable salt thereof, for use in pharmaceutical compositions for the treatment or prevention of mGluR5 receptor mediated disorders.
本发明涉及一种化合物及该化合物的使用,其化学式为1,其中R1、R2、R3、R4和R5如描述中所定义,A表示—CH═CH—或—C≡C—;B表示2,其中R6到R26、X和Y如规范中所定义或其药用可接受的盐,用于制备用于治疗或预防mGluR5受体介导的疾病的制药组合物。